ABT: Abbott Laboratories Stock

by  •  • Comments Off on ABT: Abbott Laboratories Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 200,745.85
Enterprise Value ($M) 208,465.85
Book Value ($M) 39,560.00
Book Value / Share 22.81
Price / Book 5.07
NCAV ($M) -10,526.00
NCAV / Share -6.07
Price / NCAV -19.07

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.08
Return on Equity (ROE) 0.15

Liquidity (mrq)
Quick Ratio 1.14
Current Ratio 1.60

Balance Sheet (mrq) ($M)
Current Assets 23,802.00
Assets 74,356.00
Liabilities 34,328.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 9.01 0.62
01-26 13G/A BlackRock Inc. 7.70 -3.92

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-K (MARK ONE) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURIT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-14 604,034 2,539,602 23.78
2024-11-13 575,970 2,826,925 20.37
2024-11-12 512,911 2,556,760 20.06
2024-11-11 708,531 2,708,441 26.16

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ADCT – ADC Therapeutics SA
ANRO – Alto Neuroscience, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Abbott Laboratories